EP 1796610 A2 20070620 - TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE
Title (en)
TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE
Title (de)
TRANSDERMALES THERAPEUTISCHES SYSTEM FÜR PARKINSON-KRANKHEIT
Title (fr)
SYSTEME THERAPEUTIQUE TRANSDERMIQUE POUR LA MALADIE DE PARKINSON
Publication
Application
Priority
- US 2005035257 W 20050929
- US 61376004 P 20040929
- US 61376104 P 20040929
Abstract (en)
[origin: WO2006039532A2] The invention provides a transdermal therapeutic system (TTS) containing rotigotine as the active ingredient. The TTS is useful in the treatment of Parkinson's Disease because it induces a pharmacokinetic profile where the rotigotine plasma level is high and stable.
IPC 8 full level
A61F 13/02 (2006.01); A61F 13/00 (2006.01); A61K 9/70 (2006.01); A61K 31/381 (2006.01)
CPC (source: EP)
A61K 9/7069 (2013.01); A61K 31/381 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR MK
DOCDB simple family (publication)
WO 2006039532 A2 20060413; WO 2006039532 A3 20060713; EP 1796610 A2 20070620; EP 1796610 A4 20121205; JP 2008514376 A 20080508
DOCDB simple family (application)
US 2005035257 W 20050929; EP 05802679 A 20050929; JP 2007534813 A 20050929